Prostate-specific antigen/solvent interaction analysis: A preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples

Urology

Volumn 78, Issue 3, 2011, Pages 601-605

  Stovsky, Mark ^a   Ponsky, Lee ^a   Vourganti, Srinivas ^a   Stuhldreher, Peter ^a   Siroky, Mike B ^b   Kipnis, Victor ^c   Fedotoff, Olga ^d   Mikheeva, Larissa ^d   Zaslavsky, Boris ^d   Chait, Arnon ^d   Jones, J Stephen ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veterans Administration   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Analiza Inc   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOLVENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CLINICAL EVALUATION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN SOLVENT INTERACTION ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOLVENT EFFECT; TRANSRECTAL ULTRASONOGRAPHY; UNITED STATES; URINALYSIS; UROLOGIC EXAMINATION;

ADULT; BIOPSY, NEEDLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; SENSITIVITY AND SPECIFICITY; SOLVENTS;

EID: 80052317238     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.03.071     Document Type: Article

References (23)

1. Cancer Facts & Figures 2008 2008 American Cancer Society Atlanta, GA
2. A. Jemal, E. Ward, and X. Wu Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States Cancer Epidemiol Biomarkers Pre 14 2005 590 595
3. P.S. Bunting A guide to the interpretation of serum prostate specific antigen levels Clin Biochem 28 1995 221 241
4. J.S. Jones, A. Patel, and L. Schoenfield Saturation technique does not improve cancer detection as an initial prostate biopsy strategy J Urol 175 2 2006 485 488 (Pubitemid 43067334)
5. I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
6. S. Loeb, and W.J. Catalona What to do with an abnormal PSA test Oncologist 13 2008 299 305 (Pubitemid 351679905)
7. Y. Fradet Performance of the PCA3 Urine Test on Subjects With Previous Negative Prostate Biopsies 2006 European Association of Urology poster
8. E.S. Leman, G.W. Cannon, and B.J. Trock EPCA-2: A highly specific serum marker for prostate cancer Urology 69 4 2007 714 720 (Pubitemid 46574950)
9. S.D. Mikolajczyk, L. Millar, and A.W. Partin Free prostate-specific antigen in serum is becoming more complex Urology 59 2002 797 802 (Pubitemid 34522163)
10. S. Sumi, K. Arai, and S. Kitahara Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar-chain structures of prostate-specific antigen in human prostate carcinoma J Chromatogr B 727 1999 9 14 (Pubitemid 29189270)
11. S. Prakash, and P.W. Robbins Glycotyping of prostate specific antigen Glycobiology 10 2000 173 176 (Pubitemid 30193017)
12. T. Okada, Y. Sato, and N. Kobayashi Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid Biochim Biophys Acta 60 2001 149 160 (Pubitemid 32149987)
13. R. Peracaula, G. Tabarés, and L. Royle Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins Glycobiology 13 2003 457 470 (Pubitemid 36665420)
14. P.S. Basu, R. Majhi, and S.K. Batabyal Lectin and serum-PSA interaction as a screening test for prostate cancer Clin Biochem 36 2003 373 376 (Pubitemid 36776806)
15. C. Ohyama, M. Hosono, and K. Nitta Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy Glycobiology 14 2004 671 679 (Pubitemid 39161974)
16. M.M. Jankovi, and M.M. Kosanovi Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns Clin Biochem 38 2005 58 65
17. M. Tajiri, C. Ohyama, and Y. Wada Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach Glycobiology 18 2008 2 8
18. B.Y. Zaslavsky Aqueous Two-Phase Partitioning: Physical Chemistry and Bioanalytical Applications 1994 Marcel Dekker New York
19. B.Y. Zaslavsky Bioanalytical applications of partitioning in aqueous polymer two-phase systems Anal Chem 64 1992 765A 773A
20. A. Zaslavsky, N. Gulyaeva, and A. Chait A new method for analysis of components in a mixture without preseparation: Evaluation of the concentration ratio and proteinprotein interactions Anal Biochem 296 2001 262 269 (Pubitemid 32868508)
21. I.M. Thompson, D.P. Ankerst, and C. Chi Operating characteristics of prostate-specific antigen in men with initial PSA level of 3.0 ng/mL or lower JAMA 294 2005 66 70 (Pubitemid 41002840)
22. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36 (Pubitemid 12142173)
23. N.A. Obuchowski Sample size calculations in studies of test accuracy Stat Methods Med Res 7 1998 371 392 (Pubitemid 28559255)